Who are Amphora Medical's investors?

Amphora Medical's investors include F-Prime Capital, Baird Capital, HBM Healthcare Investments, Longitude Capital.

How much funding has Amphora Medical raised?

Amphora Medical has disclosed $23.8M raised across 2 rounds.

Who acquired Amphora Medical?

Amphora Medical was acquired by Hologic.

Where is Amphora Medical headquartered?

Amphora Medical is headquartered in Maple Grove, US.

Amphora Medical

acquired by Hologic

Maple Grove, US · Founded 2011 · Delaware corporation · 4 known investors

Find your way into Amphora Medical

Acquired by Hologic May 2019 · terms undisclosed · source ↗

Amphora Medical developed a minimally invasive, cystoscopic radiofrequency ablation device (Selective Bladder Denervation System) to treat overactive bladder syndrome in women.

Healthtech

Founders & leadership

Tom RessemannExecutive

Board

Michael Liang inBoard directorManaging Partner at InVivium Capital

Robert Weisskoff inBoard directorSenior Partner at F-Prime Capital Partners

Dan SachsBoard director

Investors · 4

F-Prime CapitalCambridge · $3M – $10Mvia Robert Weisskoff · board

Baird CapitalreportedChicago

HBM Healthcare InvestmentsreportedZug

Longitude CapitalreportedMenlo Park · $10M – $30M

Reported raises · per SEC filings

Form D private placements

$23.8M disclosed across 2 rounds · 2013–2017

▶$11MraisedJul 2017 · 12 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Thomas ThalerDirector
Thomas V. RessemannExecutive Officer, Director
Nicole J. WalkerDirector
Marc GallettiDirector
Chris OwensDirector
Ketan PatelDirector

Offering amount: $35.5M
Amount sold: $11M
Minimum investment: $5.1K
Sales commissions: $700K
Placement agents: Aquilo Partners, L.P.
First sale: Jul 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$12.8MraisedJul 2015 · 8 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael LiangDirector
Dan SachsDirector
Robert WeisskoffDirector
Tom RessemannExecutive Officer, Director

Offering amount: $12.8M
Amount sold: $12.8M
Proceeds to insiders: $768K
First sale: May 2013
Incorporated: Corporation, Delaware, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Boston Scientific Backs Overactive Bladder Device Maker Amphora in $36M Round | Twin Cities Businesstcbmag.com · Jul 2017

Boston Medical helps pour series B funds into Amphora - Global Venturingglobalventuring.com · Jul 2017

Boston Scientific joins OAB device dev Amphora Medical's $36m Series B - MassDevicemassdevice.com · Jul 2017

Amphora raises $36M to trial overactive bladder treatment | Fierce Biotechfiercebiotech.com · Jul 2017

Amphora Medical Closes $35.5 Million Series B Financingglobenewswire.com · Jul 2017

Frequently asked questions

What does Amphora Medical do?: Amphora Medical developed a minimally invasive, cystoscopic radiofrequency ablation device (Selective Bladder Denervation System) to treat overactive bladder syndrome in women.
Who are Amphora Medical's investors?: Amphora Medical's investors include F-Prime Capital, Baird Capital, HBM Healthcare Investments, Longitude Capital.
How much funding has Amphora Medical raised?: Amphora Medical has disclosed $23.8M raised across 2 rounds.
Who acquired Amphora Medical?: Amphora Medical was acquired by Hologic.
Where is Amphora Medical headquartered?: Amphora Medical is headquartered in Maple Grove, US.